PMID: 2495523Mar 25, 1989Paper

Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer

Nucleic Acids Research
M A LuceroM M Zakin

Abstract

The identification of the binding sites for liver nuclear proteins present in the enhancer that control the cell specific transcription of the human apolipoprotein AII gene is reported. Five adjacent binding sites (motifs I to V) were identified. The motifs III, IV and V can be occupied differently by liver or HeLa nuclear proteins. Two hypersensitive zones (between motifs II-III and IV-V) are present only when liver nuclear extracts were tested. A first characterization of the factors reveal that motif IV interacts with the hepatic transcription factors Tf-LF1 (29) and LF-A1 (28, 30). A CCAAT binding protein, different from CTF/NF1, appears to bind to the motif II. The different binding sites share specific DNA sequences principally with 5' regulatory regions of other apolipoprotein genes.

References

May 11, 1987·Nucleic Acids Research·C S Shelley, F E Baralle
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M RaymondjeanM Yaniv
Sep 25, 1987·Nucleic Acids Research·R A Hooft van HuijsduijnenD Mathis
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T B RajavashisthA J Lusis
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·E PilgerG Kostner
Jan 1, 1983·Annual Review of Physiology·C L Bisgaier, R M Glickman
May 15, 1981·Biochemical and Biophysical Research Communications·M KuboS Tarui
Mar 1, 1981·The Journal of Clinical Investigation·D W AndersonH B Brewer
Jul 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G FagerG Bondjers

❮ Previous
Next ❯

Citations

Sep 1, 1995·DNA and Cell Biology·F RousselT Cresteil
Dec 15, 1992·Biochemical and Biophysical Research Communications·N PuzenatM Raymondjean

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.